Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea
Pooled overall remission and complete remission of nocturnal enuresis only 37.3 percent based on randomized controlled trials
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
Improvement in urinary symptoms with better preservation of ejaculatory function seen with double-n technology
Life’s Crucial 9 Negatively Linked to Overactive Bladder
Cardiovascular health measure negatively linked to OAB, with partial mediation by weight-adjusted waist index
Improvements in Prostate Cancer Mortality Plateaued From 2012 to 2021
At the same time, incidence of distant-stage prostate cancer increased
Rheumatoid Arthritis Causally Linked to Prostate Cancer
No significant associations seen for SLE or AS with prostate cancer or in reverse MR analyses
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
Median time to correct treatment significantly shorter for mpMRI-staged versus transurethral resection of bladder cancer-staged care
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa
PFAS in Drinking Water Linked to Increased Cancer Incidence
Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021
Cancer Mortality Continued to Decline Through 2022
However, increase seen in incidence in women, especially for middle-aged and younger women
PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer
M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer
